The U.S. Food and Drug Administration (FDA) recently released a new framework for implementing its Real-World Evidence (RWE) Program. Under the updated framework, the FDA has defined RWE as the “clinical evidence about the usage and potential benefits or risks of a medical product derived from analysis of” real-world data.
IVRCC builds and deploys configurable applications to facilitate the compilation and analysis of retrospective EMR data. Find out how we do it and how our technology supports this